1. Kramer M: Office of Combination Products: current initiatives. In: FDA Workshop on Novel Drug Delivery Systems: Scientific.Clinical and Regulatory Challenges. July 8, 2003. Available online at: http://www. fda.gov/ohrms/dockets/dockets/03n0203/03n-0203- ts00009-KRAMER.ppt
2. Walker E: FDA/CMS' formal collaboration will include data sharing, parallel review. Pink Sheet Daily 11 June 2004.
3. FormerFDA device chief urges companies to use FDA to help develop business strategies. Inside Health Policy 21 July 2004.
4. US Department of Health and Human Services and Health Care Financing Administration: Interagency Agreement Between the Food and Drug Administration and the Health Care Financing Administration Regarding Medicare Coverage of Certain Investigational Medical Devices. IDE memorandum D95-2. Baltimore: Health Care Financing Administration, 1995.
5. Tillman D-B: The 510(k) program: (procedures), outcomes and goals. In: AdvaMed Device Submission Workshop. June 3, 2004. Available online at: http://www. advamed.org/publicdocs/donna_bea_tillman.pdf